Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | PRKCI | P41743 | 1/20 | 1.00 |
| ▸ | PDE4B | Q07343 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | CDK2 | P24941 | 1/20 | 0.50 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phthalazinone SCHEMBL11519239 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL11516875 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL2473799 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL9617397 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL11519244 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL2962226 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL11690359 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL11516881 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL4663241 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI | |
| Phthalazinone SCHEMBL28416004 | 0.98 | PARP1 (0.96) | PARP1HSD17B10TDP1ALDH1A1PRKCI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7571 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080002-A | Phthalazinone compound and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-3504196-B1 | PROCESSES FOR PREPARING OLAPARIB | SCINOPHARM TAIWAN LTD (TW) | 2026-04-08 | — | — | EP | claimed |
| EP-4722203-A1 | 3,4-DIHYDROPHTHALAZIN-1(2H)-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Academy of Military Medical Sciences (CN) | 2026-04-08 | — | — | EP | claimed |
| EP-4713509-A1 | PROTON EXCHANGE MEMBRANE AND CATALYST-COATED PROTON EXCHANGE MEMBRANE | UOP LLC (US) | 2026-03-25 | — | — | EP | claimed |
| EP-4709906-A1 | COMPOSITE PROTON EXCHANGE MEMBRANE AND CATALYST-COATED COMPOSITE PROTON EXCHANGE MEMBRANE | UOP LLC (US) | 2026-03-18 | — | — | EP | claimed |
| US-20260060970-A1 | Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance | MITODICURE GMBH (DE) | 2026-03-05 | — | — | US | claimed |
| US-12553107-B2 | Method for catalyst recovery from catalyst-coated membranes | UOP LLC (US) | 2026-02-17 | — | — | US | claimed |
| EP-4678638-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| EP-4653437-A2 | NOVEL HETEROCYCLIC COMPOUNDS | Innovo Therapeutics Inc. (KR) | 2025-11-26 | — | — | EP | claimed |
| EP-4642763-A1 | CRYSTALLINE FORMS OF NLRP3 INFLAMMASOME INHIBITORS, CHEMICAL PROCESSES AND CHEMICAL COMPOUNDS | Astrazeneca AB (SE) | 2025-11-05 | — | — | EP | claimed |
| US-4081279-A | Photothermographic materials containing radiation sensitive quinone compounds and nitrobenzylidene dyes | EASTMAN KODAK COMPANY (US) | 1978-03-28 | — | — | US | claimed |
| US-4076534-A | Heat developable light-sensitive material | FUJI PHOTO FILM CO., LTD. (JA) | 1978-02-28 | — | — | US | claimed |
| US-4038083-A | NON-PHOTOSENSITIVE SILVER SALT AND A PHTHALAZINONE | AGFA-GEVAERT N.V. (BE) | 1977-07-26 | — | — | US | claimed |
| US-4022617-A | DIFFUSION | EASTMAN KODAK COMPANY (US) | 1977-05-10 | — | — | US | claimed |
| US-4021240-A | DIFFUSION, SILVER HALIDE OXIDIZER | EASTMAN KODAK COMPANY (US) | 1977-05-03 | — | — | US | claimed |
| US-4013473-A | THERMOGRAPHY, SUBSTITUTED PHENOL REDUCING AGENT | AGFA-GEVAERT N.V. (BE) | 1977-03-22 | — | — | US | claimed |
| US-3985565-A | Photothermographic, composition using a phenolic leuco dye as a reducing agent | EASTMAN KODAK COMPANY (US) | 1976-10-12 | — | — | US | claimed |
| US-3960908-A | AQUEOUS EMULSIONS CONTAINING SILVER SALT, SALT OF CARBOXYLIC ACID AND SOLVENT | FUJI PHOTO FILM CO., LTD. (JA) | 1976-06-01 | — | — | US | claimed |
| US-3933508-A | ORGANIC SILVER SALT, SILVER HALIDE, REDUCING AGENT, BINDER | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-20 | — | — | US | claimed |
| US-3933507-A | LIGHT INSENSITIVE SILVER SALT, POLYMETHINE SENSITIZER | AGFA-GEVAERT, A.G. (DT) | 1976-01-20 | — | — | US | claimed |